“The Role of Methylation and Epigenetics in Brain Disorders” 

 

 

Did you know that 22% of Americans are undermethylated and another 8% are overmethylated? The emerging science of epigenetics is providing insights into the impact of methylation imbalances on neurotransmission at serotonin, dopamine, norepinephrine, and NMDA receptors, and also provides a roadmap for effective nutrient therapies. William J. Walsh, PhD, presents The Role of Methylation and Epigenetics in Brain Disorders. For more details please visit at: www.walshinstitute.org/clinical-resources.html

 

The Five Biotypes of Depression and Advanced Nutrient Therapies with William Walsh, PhD

Neurotransmitters are chemical messengers that enable us to think and act. They have a dominant impact on mood, focus, concentration, anxiety, obsessions and mental well-being. Dr. William Walsh will present his findings about neurotransmitters that indicate that depression is an umbrella term for five distinct biotypes, or categories, of depression. Three of these types are not caused by fluctuating serotonin. For more details please visit at: www.walshinstitute.org/clinical-resources.html